Eashwar Somasundaram, Timothy D Smile, Ahmed Halima, James B Broughman, Chandana A Reddy, Shireen Parsai, Jacob G Scott, Chirag Shah, Timothy Chan, Shauna Campbell, Lilyana Angelov, Peter M Anderson, Stacy Zahler, Matteo Trucco, Stefanie M Thomas, Shavaughn Johnson, Nathan Mesko, Lukas Nystrom, Dale Shepard, George Thomas Budd, Peng Qi, Anthony Magnelli, Erin S Murphy
INTRODUCTION: Stereotactic body radiation therapy (SBRT) is increasingly utilized for patients with recurrent and metastatic sarcoma. SBRT affords the potential to overcome the relative radioresistance of sarcomas through delivery of a focused high biological effective dose (BED) as an alternative to invasive surgery. We report local control outcomes after metastatic sarcoma SBRT based on radiation dose and histology. METHODS: From our IRB-approved single-institution registry, all patients treated with SBRT for metastatic sarcoma between 2014 and 2020 were identified...
2022: Journal of Radiosurgery and SBRT